We observed variants in the PALB2, CHEK2, ATM, BARD1, RAD51C, BRIP1, and FANCM genes in 8.3% of the unselected BC patients and in 12.9% of the familial BC patients. This evidence concerns the gene CHEK2 and breast cancer.